USANA Health Sciences' BiOmega omega-3 supplement has received the ConsumerLab Seal of Approval, confirming its quality, purity, and accurate labeling. The product underwent independent testing alongside other omega-3 supplements and met strict standards for EPA and DHA content, freshness, and contaminant levels. This recognition supports USANA's commitment to rigorous internal testing and manufacturing standards at its FDA-registered facility. BiOmega is one of seven USANA products certified by ConsumerLab, reinforcing consumer confidence in the brand's product quality.
USANA BiOmega's recent ConsumerLab Seal of Approval is notable for readers tracking health-related products. For readers following the health sector, here is Pluang's market snapshot as of Nov 03, 2026 19:02 WIB: out of 150 priced health-sector US stocks, 74 rose and 69 fell. Notable movers include BNTX at USD 90.10 with a 1-day change of +2.94% and 100% buy order activity, COGT at USD 30.58 with a +2.86% change, and BKD at USD 10.16 with a -2.68% change.
Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...
Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...
Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...
Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...
Stella-Jones Inc. announced a conference call for November 4, 2026, at 10:00 AM EST to discuss its third quarter 2026 financial results. The call is open to investors, analysts, and interested parties and will be webcast live with a recording availab...
